海南海药子公司获富马酸伏诺拉生片药品注册批件

Core Viewpoint - Hainan Haiyao's subsidiary has received approval for a new chemical drug, indicating potential growth in its pharmaceutical portfolio and market presence [1] Group 1: Company Developments - Hainan Haiyao's wholly-owned subsidiary, Haikou Pharmaceutical Factory Co., Ltd., has obtained the Drug Registration Certificate for "Fumaric Acid Vonoprazan Tablets" from the National Medical Products Administration [1] - The registered indication for the drug is gastroesophageal reflux disease, which can be used in conjunction with appropriate antibiotics to eradicate Helicobacter pylori [1]